Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Speculative claims are labeled
In two Phase 2 clinical trials covering stasis and pressure ulcers, TB4 accelerated complete wound closure by almost a month in patients who achieved full healing representing one of the most substantial healing acceleration outcomes observed for a peptide compound in a controlled clinical investigation
For example, switching where the shot is given can help avoid irritation
Our scientific and technical teams provide flexible solutions across the full development cyclefrom early research to regulatory submission
US$ 29.73
US$ 27.45
US$ 29.40
US$ 23.43
US$ 26.46
US$ 25.26
US$ 28.62
US$ 27.28
